Mirae Asset Global Investments Co., Ltd. - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 93 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2020. The put-call ratio across all filers is 0.10 and the average weighting 1.3%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$5,756,000
+24.8%
48,615
+24.4%
0.02%
+17.6%
Q4 2020$4,614,000
+12.6%
39,071
+6.0%
0.02%
-15.0%
Q3 2020$4,096,000
-14.0%
36,856
-20.9%
0.02%
-31.0%
Q2 2020$4,762,000
-4.1%
46,597
+1.3%
0.03%
-25.6%
Q1 2020$4,964,000
-35.6%
45,995
-30.5%
0.04%
-18.8%
Q4 2019$7,705,000
-1.2%
66,210
-2.8%
0.05%
-11.1%
Q3 2019$7,800,00068,1410.05%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2020
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders